Oberweis Asset Management Inc Axonics, Inc. Transaction History

Oberweis Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $844,383 - $1.03 Million	-14,900 Reduced 8.35%	163,570 $11.3 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $832,053 - $1.07 Million	16,850 Added 10.43%	178,470 $11.1 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $1.76 Million - $2.26 Million	36,180 Added 28.84%	161,620 $9.07 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $1.43 Million - $1.79 Million	29,700 Added 31.02%	125,440 $6.33 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $5.04 Million - $6.45 Million	95,740 New	95,740 $5.22 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.